Investigators at The Saban Research Institute of Children’s Hospital Los Angeles have found that amniotic fluid stem cells (AFSC) can slow the progression of chronic kidney disease.
Mitchell E. Geffner, MD, has been appointed division chief and director of fellowship training for the Center for Endocrinology, Diabetes, and Metabolism at Children’s Hospital Los Angeles. The Center is among the nation’s best and is ranked fifth nationally for pediatric endocrinology and diabetes care by U.S. News & World Report.
The Latino Business Chamber of Greater Los Angeles (LBC-GLA) selected Children’s Hospital Los Angeles as the Nonprofit Business of the Year during its Third Annual Awards luncheon held this week in downtown Los Angeles.
Investigators at The Saban Research Institute of Children’s Hospital Los Angeles have found that amniotic fluid stem cells (AFSC) can slow the progression of chronic kidney disease. 
